EUVIMEDEUVIMED entdecken
Crossref

Plasma homeostatic chemokines CCL19 and CCL21 and the prognosis of ischemic stroke in two Chinese prospective cohorts

Bizhong Che iD, Chongke Zhong iD, Jigang Du iD, Mengyuan Miao iD, Mengyao Shi, Yanbo Peng, Pinni Yang iD, Daoxia Guo iD, Jing Chen, Aili Wang, Tan Xu, Yonghong Zhang und 1 weitere

European Journal of Neurology · 2023

DOI: 10.1111/ene.15959 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neurology, 2023. Verfasst von Bizhong Che und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Suzho…. Hauptthemen laut MEDLINE: Chemokine CCL19, Chemokine CCL21, Ischemic Stroke. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The homeostatic chemokines CCL19 and CCL21 are involved in carotid plaque vulnerability and post‐ischemic neuroinflammatory responses. This study aimed to examine the prognostic values of CCL19 and CCL21 in ischemic stroke.

Methods

Plasma CCL19 and CCL21 were measured in 4483 ischemic stroke patients from two independent cohorts of CATIS (China Antihypertensive Trial in Acute Ischemic Stroke) and IIPAIS (Infectious Factors, Inflammatory Markers, and Prognosis of Acute Ischemic Stroke), and participants were followed up at 3 months after stroke. The primary outcome was the composite outcome of death or major disability. The associations of CCL19 and CCL21 levels with the primary outcome were examined.

Results

In CATIS, multivariable‐adjusted odds ratios of the primary outcome in the highest quartiles of CCL19 and CCL21 compared with the lowest quartiles were 2.06 and 2.62, respectively. In IIPAIS, odds ratios of the primary outcome in the highest quartiles of CCL19 and CCL21 were 2.81 and 2.78 compared with the lowest quartiles, respectively. In the pooled analysis of the two cohorts, odds ratios of the primary outcome associated with the highest quartiles of CCL19 and CCL21 were 2.24 and 2.66, respectively. Similar findings were observed in the analysis with major disability, death, and the composite outcome of death or cardiovascular events as the secondary study outcomes. Adding CCL19 and CCL21 to conventional risk factors significantly improved risk reclassification and discrimination for adverse outcomes.

Conclusions

Both CCL19 and CCL21 levels were independently associated with adverse outcomes within 3 months after ischemic stroke and should be further investigated for risk stratification and potential therapeutic targets of ischemic stroke.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemokine CCL19Chemokine CCL21Ischemic StrokeHumansEast Asian PeoplePrognosisProspective Studies

Stichwörter der Autor:innen

adverse outcomecardiovascular eventhomeostatic chemokinesischemic stroke

Substanzen

CCL19 protein, humanCCL21 protein, humanChemokine CCL19Chemokine CCL21

Autor:innen und Institutionen

  • Department of Epidemiology, School of Public Health and Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Suzhou Medical College of Soochow University, Suzhou, China.
  • Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana, USA.
  • Department of Neurology, Affiliated Hospital of North China University of Science and Technology, Hebei, China.
  • Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA.

ORCID-Profile: Bizhong Che, Chongke Zhong, Jigang Du, Mengyuan Miao, Pinni Yang, Daoxia Guo

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Che, B., Zhong, C., Du, J., Miao, M., Shi, M., Peng, Y., Yang, P., Guo, D., Chen, J., Wang, A., Xu, T., Zhang, Y., & He, J. (2023). Plasma homeostatic chemokines CCL19 and CCL21 and the prognosis of ischemic stroke in two Chinese prospective cohorts. European Journal of Neurology. https://doi.org/10.1111/ene.15959

Vancouver

Che B, Zhong C, Du J, Miao M, Shi M, Peng Y, et al. Plasma homeostatic chemokines CCL19 and CCL21 and the prognosis of ischemic stroke in two Chinese prospective cohorts. European Journal of Neurology. 2023. doi:10.1111/ene.15959

BibTeX
@article{Che2023,
  author = {Che, Bizhong and Zhong, Chongke and Du, Jigang and Miao, Mengyuan and Shi, Mengyao and Peng, Yanbo and Yang, Pinni and Guo, Daoxia and Chen, Jing and Wang, Aili and Xu, Tan and Zhang, Yonghong and He, Jiang},
  title = {Plasma homeostatic chemokines CCL19 and CCL21 and the prognosis of ischemic stroke in two Chinese prospective cohorts},
  journal = {European Journal of Neurology},
  year = {2023},
  doi = {10.1111/ene.15959}
}
Kostenlos starten →